Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1432-1433, 2004-01, pp. : 16-16
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Moxifloxacin: faster relief of symptoms in AECB?
Inpharma, Vol. 1, Iss. 1263, 2000-01 ,pp. :
Access to resources
Recommend
Moxifloxacin a better option for AECB than levofloxacin?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 300, 2001-01 ,pp. :
Oral pristinamycin superior to penicillin?
Inpharma, Vol. 1, Iss. 1361, 2002-01 ,pp. :
Moxifloxacin cost effective versus ceftriaxone in AECB
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 389, 2002-01 ,pp. :
Moxifloxacin cost effective versus ceftriaxone in AECB
Inpharma, Vol. 1, Iss. 1364, 2002-01 ,pp. :